As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

The rising use of GLP-1 agonists to help manage the obesity epidemic is not only reshaping how consumers taking the ...

Eli Lilly then spurred it on further with tirzepatide — a GLP-1RA and gastric inhibitory polypeptide (GIP) agonist.

Eli Lilly is suing four telehealth companies that prescribe compounded versions of the pharmaceutical company's weight loss medications. Lilly filed four lawsuits on Wednesday claiming telehealth ...

Nestle SA is launching GLP-1-friendly beverages under its Boost brand that contain a proprietary whey protein microgel ...

Finding an inability of brand name GLP-1 manufacturers to keep up with patient demand for approved GLP-1 drugs, the FDA temporarily placed many of the approved GLP-1 drugs on the FDA shortage list ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

"ACC 25: GLP-1 receptor agonists emerge for treating atrial fibrillation" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.